- In March 2022, the U.S. Food and Drug Administration (FDA) approved a new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a leading medical technology company. Named Rika, this next-generation automated system is designed to enhance the experience of both plasma center staff and donors. It features built-in safety mechanisms to reduce operator errors and can collect plasma in 35 minutes or less. Rika was set to launch in the spring through a limited market release at CSL Plasma collection centers in the Denver, Colorado area, with broader deployment planned across additional CSL Plasma locations later in 2022.
- In June 2021, Cardinal Health Nuclear & Precision Health Solutions secured FDA approval for LYMPHOSEEK Paediatric Indication, propelling company growth in the blood plasma collection market, with expanded offerings catering to pediatric patients, strengthening market demand and revenue
- In June 2021, Octapharma AG's octagam gained European and German approvals for dermatomyositis in adults, augmenting the company's presence in the blood plasma collection market, particularly in Europe and Germany. This diversification strengthens market competitiveness and revenue potential
